JNJ vs BSX
By Alex · Tickerpine
Johnson & Johnson vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BSX |
|---|---|---|
| Price | $285.75 | $44.34 |
| Market cap | $687.89B | $64.27B |
| P/E ratio | 43.4 | 18.7 |
| ROE | 20.02% | 14.12% |
| Profit margin | 16.20% | 16.62% |
| Revenue growth | 5.90% | 1.40% |
| Dividend yield | 1.88% | 0.00% |
| Beta | 0.20 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BSX in plain English
- JNJ is the bigger company — about 10.7× the market cap of BSX.
- BSX is cheaper on earnings (P/E 18.7 vs 43.4).
- JNJ earns a higher return on equity (20% vs 14%).
- JNJ is growing revenue faster (6% vs 1%).
- JNJ pays a dividend (1.88%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.